GENERATOR Breast DataMart-The Novel Breast Cancer Data Discovery System for Research and Monitoring: Preliminary Results and Future Perspectives.
DataMart
breast cancer
healthcare
predictive model
real world data
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
22 Jan 2021
22 Jan 2021
Historique:
received:
30
12
2020
revised:
18
01
2021
accepted:
20
01
2021
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
28
1
2021
Statut:
epublish
Résumé
Artificial Intelligence (AI) is increasingly used for process management in daily life. In the medical field AI is becoming part of computerized systems to manage information and encourage the generation of evidence. Here we present the development of the application of AI to IT systems present in the hospital, for the creation of a DataMart for the management of clinical and research processes in the field of breast cancer. A multidisciplinary team of radiation oncologists, epidemiologists, medical oncologists, breast surgeons, data scientists, and data management experts worked together to identify relevant data and sources located inside the hospital system. Combinations of open-source data science packages and industry solutions were used to design the target framework. To validate the DataMart directly on real-life cases, the working team defined tumoral pathology and clinical purposes of proof of concepts (PoCs). Data were classified into "Not organized, not 'ontologized' data", "Organized, not 'ontologized' data", and "Organized and 'ontologized' data". Archives of real-world data (RWD) identified were platform based on ontology, hospital data warehouse, PDF documents, and electronic reports. Data extraction was performed by direct connection with structured data or text-mining technology. Two PoCs were performed, by which waiting time interval for radiotherapy and performance index of breast unit were tested and resulted available. GENERATOR Breast DataMart was created for supporting breast cancer pathways of care. An AI-based process automatically extracts data from different sources and uses them for generating trend studies and clinical evidence. Further studies and more proof of concepts are needed to exploit all the potentials of this system.
Sections du résumé
BACKGROUND
BACKGROUND
Artificial Intelligence (AI) is increasingly used for process management in daily life. In the medical field AI is becoming part of computerized systems to manage information and encourage the generation of evidence. Here we present the development of the application of AI to IT systems present in the hospital, for the creation of a DataMart for the management of clinical and research processes in the field of breast cancer.
MATERIALS AND METHODS
METHODS
A multidisciplinary team of radiation oncologists, epidemiologists, medical oncologists, breast surgeons, data scientists, and data management experts worked together to identify relevant data and sources located inside the hospital system. Combinations of open-source data science packages and industry solutions were used to design the target framework. To validate the DataMart directly on real-life cases, the working team defined tumoral pathology and clinical purposes of proof of concepts (PoCs).
RESULTS
RESULTS
Data were classified into "Not organized, not 'ontologized' data", "Organized, not 'ontologized' data", and "Organized and 'ontologized' data". Archives of real-world data (RWD) identified were platform based on ontology, hospital data warehouse, PDF documents, and electronic reports. Data extraction was performed by direct connection with structured data or text-mining technology. Two PoCs were performed, by which waiting time interval for radiotherapy and performance index of breast unit were tested and resulted available.
CONCLUSIONS
CONCLUSIONS
GENERATOR Breast DataMart was created for supporting breast cancer pathways of care. An AI-based process automatically extracts data from different sources and uses them for generating trend studies and clinical evidence. Further studies and more proof of concepts are needed to exploit all the potentials of this system.
Identifiants
pubmed: 33498985
pii: jpm11020065
doi: 10.3390/jpm11020065
pmc: PMC7911086
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Eur J Intern Med. 2018 Jul;53:1-2
pubmed: 29807851
JAMA Netw Open. 2020 Mar 2;3(3):e200265
pubmed: 32119094
Breast J. 2018 Sep;24(5):811-815
pubmed: 29687531
Med Phys. 2020 Nov 7;:
pubmed: 33159812
Curr Oncol. 2020 Apr;27(2):e216-e221
pubmed: 32489271
Radiother Oncol. 2013 Oct;109(1):159-64
pubmed: 23993399
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2722-2730
pubmed: 31203421
J Contemp Brachytherapy. 2016 Aug;8(4):336-43
pubmed: 27648088
Breast. 2020 Feb;49:25-32
pubmed: 31677530
Cureus. 2018 Apr 13;10(4):e2475
pubmed: 29904616
J Contemp Brachytherapy. 2017 Dec;9(6):540-547
pubmed: 29441098
N Engl J Med. 1985 Mar 14;312(11):665-73
pubmed: 3883167
Sci Rep. 2020 Oct 12;10(1):17046
pubmed: 33046779
Eur J Intern Med. 2018 Jul;53:73-78
pubmed: 29477755
NPJ Syst Biol Appl. 2020 Jun 2;6(1):16
pubmed: 32487991
J Contemp Brachytherapy. 2018 Jun;10(3):260-266
pubmed: 30038647
N Engl J Med. 1996 May 23;334(21):1356-61
pubmed: 8614420
Diagn Pathol. 2020 Jul 4;15(1):80
pubmed: 32622359
Eur J Cancer. 2017 Nov;86:59-81
pubmed: 28963914
J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64
pubmed: 8931610
Cancer Lett. 1994 Mar 15;77(2-3):163-71
pubmed: 8168063